已收录 268921 条政策
 政策提纲
  • 暂无提纲
Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-γTargeting Gene Therapy
[摘要] Systemic lupus erythematosus (SLE: lupus) is a chronic complicated autoimmune disease and pathogenesis is still unclear.However, key cytokines have been recognized. Interferon (IFN)-γand also IFNα/βare of particular importance. Depending on the concept that lupus is a helper T(Th)1 disease and that dendritic cells (DCs) determine the direction of lupus, balance shift of Th1/Th2 and immunogenic/tolerogenic DCs is reviewed for therapy.(IFN)-γ- andIFN-α/β-targeted(gene) therapies are introduced. These consist of Th1/Th2 balance shift and elimination of IFN-γand IFN-γ-related cytokines such as (interleukin)IL-12 and IL-18.Other approaches include suppression of immunocompetent cells, normalization of abnormal T-cell function, costimulation blockade, B lymphocyte stimulator (Blys) blockade, and suppression of nephritic kidney inflammation. Moreover, balance shift of IFN-α/βand tumor necrosis factor (TNF)-αtogether with regulatory T(Treg) cells are briefely introduced. Clinical application will be discussed.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 基础医学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文